CONTEPO (fosfomycin) for injection is a revolutionary antibiotic solution developed for the treatment of complicated urinary tract infections (cUTIs). This game-changing formula, provided by Nabriva Therapeutics, is known for providing a broad spectrum of bactericidal activity against multidrug-resistant strains. CONTEPO is now the first intravenous epoxide antibiotic available in the USA, offering new hope to patients suffering from complex infections.